What is the most likely diagnosis in an 18‑year‑old female who has periventricular white‑matter hypodensities and enlarged cerebrospinal fluid spaces?

Most Likely Diagnosis: Vanishing White Matter Disease (VWMD)

In an 18-year-old female presenting with periventricular white matter hypodensities and enlarged CSF spaces (cerebral volume loss), vanishing white matter disease is the most likely diagnosis, particularly given the young age at presentation and the characteristic imaging pattern of white matter loss with compensatory volume changes.

Diagnostic Reasoning

Age-Specific Considerations

The patient's age of 18 years is critical to narrowing the differential diagnosis. While CSF1R-related leukoencephalopathy typically presents with a median onset age of 41 years (women at 40 years) 1, VWMD can present in young adults and is one of the most prevalent inherited leukoencephalopathies affecting this age group 2. The mean age of clinical onset in female patients with adult-onset VWMD is 36.8 years, but the disease can manifest in late adolescence 2.

Imaging Pattern Analysis

The combination of findings is highly characteristic:

• Periventricular white matter hypodensities: This represents the hallmark of VWMD, where progressive white matter loss occurs 2, 3. The periventricular distribution is classic for this condition.

• Prominent CSF spaces with cerebral volume loss: This reflects the "vanishing" nature of the white matter, where brain tissue is progressively replaced by CSF-filled spaces 2, 3. This is distinct from simple atrophy and represents actual tissue loss with compensatory CSF expansion.

Key Differentiating Features

Why not CSF1R-related leukoencephalopathy?

• Age mismatch: CSF1R disease median onset is 41 years 1
• CSF1R typically shows cortical and callosal atrophy (29% with callosal atrophy) 1, but the primary finding is white matter hyperintensities on T2/FLAIR, not the "vanishing" pattern with CSF replacement
• The prominent CSF spaces due to volume loss at age 18 is more consistent with VWMD's progressive tissue loss

Why not enlarged perivascular spaces?

• Enlarged perivascular spaces (Virchow-Robin spaces) typically present in older adults (mean age 60-70 years) 4, 5, 6
• They appear as discrete cystic spaces following CSF signal with complete FLAIR suppression 5, 7, not diffuse periventricular hypodensities
• They don't cause generalized cerebral volume loss

Why not Binswanger's disease?

• Binswanger's disease occurs in older adults (seventh decade) 8
• Associated with hypertension and vascular risk factors
• Age 18 makes this diagnosis extremely unlikely

Clinical Approach

Essential Next Steps

1. Obtain detailed history focusing on:

   • Neurological symptom progression (motor dysfunction, cerebellar ataxia, cognitive decline)
   • Triggering events (infections, minor head trauma, stress) that characteristically worsen VWMD
   • Family history of similar neurological conditions (autosomal recessive inheritance)
   • In females: menstrual history (ovarian dysfunction can precede neurological symptoms in VWMD) 2

2. Complete MRI brain with specific sequences:

   • T2-weighted and FLAIR imaging to assess white matter changes
   • T1-weighted to evaluate tissue loss
   • Look for rarefaction and cystic degeneration of white matter
   • Assess for spinal cord involvement if available

3. Genetic testing:

   • EIF2B1-5 gene panel is diagnostic for VWMD 2, 3
   • The c.338 G > A mutation in EIF2B5 (p.Arg113His) is most common 2
   • EIF2B2 and EIF2B3 mutations also reported 2, 3

Critical Management Considerations

Immediate priorities:

• Avoid triggering events: infections, fever, minor head trauma, extreme stress
• These can precipitate rapid neurological deterioration in VWMD patients
• No curative treatment exists; management is supportive and preventive 2

Prognostic counseling:

• VWMD is progressive with gradual neurological decline
• Early recognition allows for genetic counseling for family planning
• Symptom management focuses on preventing acute deteriorations

Common Pitfalls to Avoid

• Don't dismiss based on age: While VWMD is often considered pediatric, 15% of cases are adult-onset 3
• Don't confuse with multiple sclerosis: The diffuse, symmetric periventricular involvement with volume loss differs from MS plaques
• Don't overlook systemic features: Female patients may have ovarian dysfunction and metabolic abnormalities 2
• Don't delay genetic testing: This is the definitive diagnostic test and has implications for family members

The combination of young age, periventricular white matter hypodensities, and cerebral volume loss creates a highly specific pattern most consistent with vanishing white matter disease, warranting immediate genetic evaluation.